Search Within

Shanu Modi

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (56)
  2. Journal Article (44)
  3. Review (4)
Groups
  1. Breast Medicine Service (104)
  2. Department of Medicine (104)
  3. GSK Faculty (104)
  4. Solid Tumor Oncology Division (104)
  5. Survivorship Research (68)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (64)

More Groups

People
  1. Sarat Chandarlapaty (49)
  2. Clifford Hudis (46)
  3. Sujata Patil (32)
  4. Larry Norton (29)
  5. Komal Jhaveri (25)
  6. Chau Dang (22)

More People

Years
  1. 2024 (8)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (6)
  5. 2020 (9)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Cancer Research (24)
  3. Clinical Cancer Research (6)
  4. Breast Cancer Research and Treatment (5)
  5. Annals of Oncology (4)
  6. Clinical Breast Cancer (4)

More Publications

Publishers
  1. American Association for Cancer Research (31)
  2. American Society of Clinical Oncology (30)
  3. Nature Publishing Group (9)
  4. Elsevier Inc. (6)
  5. Oxford University Press (6)
  6. Springer (6)

More Publishers

Results (104)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers
    Meeting Abstract

    Drago, J. Z.; Pareja, F.; Jhaveri, K. L.; Walsh, E. M.; Ku, G. Y.; Maron, S. B.; Janjigian, Y. Y.; Robson, M. E.; Reis-Filho, J. S.; Modi, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation
    Journal Article

    Rodina, A.; Xu, C.; Digwal, C. S.; Joshi, S.; Patel, Y.; Santhaseela, A. R.; Bay, S.; Merugu, S.; Alam, A.; Yan, P.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
    Review

    Tarantino, P.; Viale, G.; Press, M. F.; Hu, X.; Penault-Llorca, F.; Bardia, A.; Batistatou, A.; Burstein, H. J.; Carey, L. A.; Cortes, J.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: A feasibility study
    Journal Article

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer
    Meeting Abstract

    Ferraro, E.; Razavi, P.; Chandarlapaty, S.; Modi, S.; Wen, H. Y.; Brogi, E.; Norton, L.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save